FDA panel convenes on SSRIs and pregnancy amid ongoing debate over risk, efficacy - Contemporary OB/GYN

Submitted by Anonymous (not verified) on Mon, 07/21/2025 - 17:51

FDA panel convenes on SSRIs and pregnancy amid ongoing debate over risk, efficacy  Contemporary OB/GYN